Related references
Note: Only part of the references are listed.Role of checkpoint kinase 1 (Chk1) in the mechanisms of resistance to histone deacetylase inhibitors
Ju-Hee Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Histone deacetylase inhibitors and HIV latency
David M. Margolis
CURRENT OPINION IN HIV AND AIDS (2011)
Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+Cell Infection
Nancie M. Archin et al.
PLOS ONE (2010)
Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair
J-H. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors
Nancie M. Archin et al.
AIDS (2009)
Short Communication: Activation of Latent HIV Type 1 Gene Expression by Suberoylanilide Hydroxamic Acid (SAHA), an HDAC Inhibitor Approved for Use to Treat Cutaneous T Cell Lymphoma
Leonard C. Edelstein et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
Nancie M. Archin et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells
Xavier Contreras et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A Limited Group of Class I Histone Deacetylases Acts To Repress Human Immunodeficiency Virus Type 1 Expression
Kara S. Keedy et al.
JOURNAL OF VIROLOGY (2009)
Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells
Nancy M. Archin et al.
AIDS (2008)
Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir
Nathalie Sagot-Lerolle et al.
AIDS (2008)
Stability of the latent reservoir for HIV-1 in patients receiving valproic acid
Janet D. Siliciano et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
A study to determine the effects of food and multiple dosing on the pharmacokinetics of vorinostat given orally to patients with advanced cancer
Eric H. Rubin et al.
CLINICAL CANCER RESEARCH (2006)
G1 cell-cycle arrest and apoptosis by histone deacetylase inhibition in MLL-AF9 acute myeloid leukemia cells is p21 dependent and MLL-AF9 independent
R. Tonelli et al.
LEUKEMIA (2006)
TaqMan RT-PCR and VERSANT® HIV-1 RNA 3.0 (bDNA) assay -: Quantification of HIV-1 RNA viral load in breast milk
K Israel-Ballard et al.
JOURNAL OF CLINICAL VIROLOGY (2005)
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
G Lehrman et al.
LANCET (2005)
High turbulence liquid chromatography online extraction and tandem mass spectrometry for the simultaneous determination of suberoylanilide hydroxamic acid and its two metabolites in human serum
LH Du et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2005)
Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1
CY Gui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Guideline to reference gene selection for quantitative real-time PCR
A Radonic et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma
S Palmer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo
M Hermankova et al.
JOURNAL OF VIROLOGY (2003)
Inclusion of full length human immunodeficiency virus type 1 (HIV-1) gag sequences in viral recombinants applied to drug susceptibility phenotyping
LH Robinson et al.
JOURNAL OF VIROLOGICAL METHODS (2002)
Share Paper
